Lv5
1018 积分 2024-11-18 加入
Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigens
28天前
已完结
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
28天前
已完结
The B7-H3 (CD276) pathway: emerging biology and clinical therapeutics
2个月前
已完结
Claudin 18.2 as a novel therapeutic target
3个月前
已完结
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
4个月前
已完结
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
7个月前
已完结
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
8个月前
已完结
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia
8个月前
已完结
Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis
9个月前
已完结
Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
9个月前
已完结
皖公网安备34019202002308
